Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Biomolecules ; 13(5)2023 05 11.
Article in English | MEDLINE | ID: mdl-37238689

ABSTRACT

D-serine is an important signalling molecule, which activates N-methyl D-aspartate receptors (NMDARs) in conjunction with its fellow co-agonist, the neurotransmitter glutamate. Despite its involvement in plasticity and memory related to excitatory synapses, its cellular source and sink remain a question. We hypothesise that astrocytes, a type of glial cell that surrounds synapses, are likely candidates to control the extracellular concentration of D-Serine by removing it from the synaptic space. Using in situ patch clamp recordings and pharmacological manipulation of astrocytes in the CA1 region of the mouse hippocampal brain slices, we investigated the transport of D-serine across the plasma membrane. We observed the D-serine-induced transport-associated currents upon puff-application of 10 mM D-serine on astrocytes. Further, O-benzyl-L-serine and trans-4-hydroxy-proline, known substrate inhibitors of the alanine serine cysteine transporters (ASCT), reduced D-serine uptake. These results indicate that ASCT is a central mediator of astrocytic D-serine transport and plays a role in regulating its synaptic concentration by sequestration into astrocytes. Similar results were observed in astrocytes of the somatosensory cortex and Bergmann glia in the cerebellum, indicative of a general mechanism expressed across a range of brain areas. This removal of synaptic D-serine and its subsequent metabolic degradation are expected to reduce its extracellular availability, influencing NMDAR activation and NMDAR-dependent synaptic plasticity.


Subject(s)
Astrocytes , Long-Term Potentiation , Mice , Animals , Long-Term Potentiation/physiology , Astrocytes/metabolism , Synapses/metabolism , Hippocampus/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Serine/metabolism , Brain/metabolism
2.
Int J Mol Sci ; 19(4)2018 Mar 21.
Article in English | MEDLINE | ID: mdl-29561757

ABSTRACT

Astrocytes are glial cells that have an intimate physical and functional association with synapses in the brain. One of their main roles is to recycle the neurotransmitters glutamate and gamma-aminobutyric acid (GABA), as a component of the glutamate/GABA-glutamine cycle. They perform this function by sequestering neurotransmitters and releasing glutamine via the neutral amino acid transporter SNAT3. In this way, astrocytes regulate the availability of neurotransmitters and subsequently influence synaptic function. Since many plasma membrane transporters are regulated by protein kinase C (PKC), the aim of this study was to understand how PKC influences SNAT3 glutamine transport in astrocytes located immediately adjacent to synapses. We studied SNAT3 transport by whole-cell patch-clamping and fluorescence pH imaging of single astrocytes in acutely isolated brainstem slices, adjacent to the calyx of the Held synapse. Activation of SNAT3-mediated glutamine transport in these astrocytes was reduced to 77 ± 6% when PKC was activated with phorbol 12-myristate 13-acetate (PMA). This effect was very rapid (within ~20 min) and eliminated by application of bisindolylmaleimide I (Bis I) or 7-hydroxystaurosporine (UCN-01), suggesting that activation of conventional isoforms of PKC reduces SNAT3 function. In addition, cell surface biotinylation experiments in these brain slices show that the amount of SNAT3 in the plasma membrane is reduced by a comparable amount (to 68 ± 5%) upon activation of PKC. This indicates a role for PKC in dynamically controlling the trafficking of SNAT3 transporters in astrocytes in situ. These data demonstrate that PKC rapidly regulates the astrocytic glutamine release mechanism, which would influence the glutamine availability for adjacent synapses and control levels of neurotransmission.


Subject(s)
Amino Acid Transport Systems, Neutral/metabolism , Astrocytes/metabolism , Protein Kinase C/metabolism , Synapses/metabolism , Animals , Brain/metabolism , Endocytosis , Enzyme Activation , Isoenzymes/metabolism , Mice, Inbred C57BL , Rats, Wistar
3.
Glia ; 65(6): 900-916, 2017 06.
Article in English | MEDLINE | ID: mdl-28272791

ABSTRACT

The release of glutamine from astrocytes adjacent to synapses in the central nervous system is thought to play a vital role in the mechanism of glutamate recycling and is therefore important for maintaining excitatory neurotransmission. Here we investigate the nature of astrocytic membrane transport of glutamine in rat brainstem slices, using electrophysiological recording and fluorescent imaging of pHi and Nai+. Glutamine application to perisynaptic astrocytes induced a membrane current, caused by activation of system A (SA) family transporters. A significant electroneutral component was also observed, which was mediated by the system N (SN) family transporters. This response was stimulated by glutamine (KM of 1.57 mM), histidine, and asparagine, but not by leucine or serine, indicating activation of the SNAT3 isoform of SN. We hypothesized that increasing the [Na+ ]i would alter the SNAT3 transporter equilibrium, thereby stimulating glutamine release. In support of this hypothesis, we show that SNAT3 transport can be driven by changing cation concentration and that manipulations to raise [Na+ ]i (activation of excitatory amino acid transporters (EAATs), SA transporters or AMPA receptors) all directly influence SNAT3 transport rate. A kinetic model of glutamine fluxes is presented, which shows that EAAT activation causes the release of glutamine, driven mainly by the increased [Na+ ]i . These data demonstrate that SNAT3 is functionally active in perisynaptic astrocytes in situ. As a result, astrocytic Nai+ signaling, as would be stimulated by neighboring synaptic activity, has the capacity to stimulate astrocytic glutamine release to support glutamate recycling.


Subject(s)
Amino Acid Transport Systems, Neutral/metabolism , Astrocytes/metabolism , Glutamine/metabolism , Intracellular Space/metabolism , Sodium/metabolism , Synapses/metabolism , Amino Acid Transport System A/metabolism , Animals , Astrocytes/drug effects , Brain Stem/drug effects , Brain Stem/metabolism , Cations, Monovalent/metabolism , Female , Glutamate Plasma Membrane Transport Proteins/metabolism , Hydrogen-Ion Concentration , Intracellular Space/drug effects , Kinetics , Lithium/metabolism , Male , Models, Neurological , Rats, Wistar , Receptors, AMPA/metabolism , Synapses/drug effects , Tissue Culture Techniques
4.
Glia ; 64(10): 1655-66, 2016 10.
Article in English | MEDLINE | ID: mdl-26566753

ABSTRACT

The transmembrane Na(+) concentration gradient is an important source of energy required not only to enable the generation of action potentials in excitable cells, but also for various transmembrane transporters both in excitable and non-excitable cells, like astrocytes. One of the vital functions of astrocytes in the central nervous system (CNS) is to regulate neurotransmitter concentrations in the extracellular space. Most neurotransmitters in the CNS are removed from the extracellular space by Na(+) -dependent neurotransmitter transporters (NeuTs) expressed both in neurons and astrocytes. Neuronal NeuTs control mainly phasic synaptic transmission, i.e., synaptically induced transient postsynaptic potentials, while astrocytic NeuTs contribute to the termination of phasic neurotransmission and modulate the tonic tone, i.e., the long-lasting activation of extrasynaptic receptors by neurotransmitter that has diffused out of the synaptic cleft. Consequently, local intracellular Na(+) ([Na(+) ]i ) transients occurring in astrocytes, for example via the activation of ionotropic neurotransmitter receptors, can affect the driving force for neurotransmitter uptake, in turn modulating the spatio-temporal profiles of neurotransmitter levels in the extracellular space. As some NeuTs are close to thermodynamic equilibrium under resting conditions, an increase in astrocytic [Na(+) ]i can stimulate the direct release of neurotransmitter via NeuT reversal. In this review we discuss the role of astrocytic [Na(+) ]i changes in the regulation of uptake/release of neurotransmitters. It is emphasized that an activation of one neurotransmitter system, including either its ionotropic receptor or Na(+) -coupled co-transporter, can strongly influence, or even reverse, other Na(+) -dependent NeuTs, with potentially significant consequences for neuronal communication. GLIA 2016;64:1655-1666.


Subject(s)
Astrocytes/physiology , Signal Transduction/physiology , Sodium/metabolism , Synaptic Transmission/physiology , Animals
5.
J Neurosci Res ; 93(7): 1031-44, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25648608

ABSTRACT

Glutamate released from synapses during excitatory neurotransmission must be rapidly recycled to maintain neuronal communication. This review evaluates data from physiological experiments at hippocampal CA3 to CA1 synapses and the calyx of Held synapse in the brainstem to analyze quantitatively the rates of release and resupply of glutamate required to sustain neurotransmission. We calculate that, without efficient recycling, the presynaptic glutamate supply will be exhausted within about a minute of normal synaptic activity. We also discuss replenishment of the presynaptic pool by diffusion from the soma, direct uptake of glutamate back into the presynaptic terminal, and uptake of glutamate precursor molecules. Diffusion of glutamate from the soma is calculated to be fast enough to resupply presynaptic glutamate in the hippocampus but not at the calyx of Held. However, because the somatic cytoplasm will also quickly run out of glutamate and synapses can function continually even if the presynaptic axon is severed, mechanisms other than diffusion must be present to resupply glutamate for release. Direct presynaptic uptake of glutamate is not present at the calyx of Held but may play a role in glutamate recycling in the hippocampus. Alternatively, glutamine or tricarboxylic acid cycle intermediates released from glia can serve as a precursor for glutamate in synaptic terminals, and we calculate that the magnitude of presynaptic glutamine uptake is sufficient to supply enough glutamate to sustain neurotransmission. The nature of these mechanisms, their relative abundance, and the co-ordination between them remain areas of intensive investigation.


Subject(s)
Brain/cytology , Glutamic Acid/metabolism , Neurons/physiology , Presynaptic Terminals/metabolism , Synapses/physiology , Synaptic Transmission/physiology , Animals , Excitatory Postsynaptic Potentials
6.
Endocrinology ; 155(10): 3732-8, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25051442

ABSTRACT

The phenomenon commonly described as the middle-age spread is the result of elevated adiposity accumulation throughout adulthood until late middle-age. It is a clinical imperative to gain a greater understanding of the underpinnings of age-dependent obesity and, in turn, how these mechanisms may impact the efficacy of obesity treatments. In particular, both obesity and aging are associated with rewiring of a principal brain pathway modulating energy homeostasis, promoting reduced activity of satiety pro-opiomelanocortin (POMC) neurons within the arcuate nucleus of the hypothalamus (ARC). Using a selective ARC-deficient POMC mouse line, here we report that former obesity medications augmenting endogenous 5-hydroxytryptamine (5-HT) activity d-fenfluramine and sibutramine require ARC POMC neurons to elicit therapeutic appetite-suppressive effects. We next investigated whether age-related diminished ARC POMC activity therefore impacts the potency of 5-HT obesity pharmacotherapies, lorcaserin, d-fenfluramine, and sibutramine and report that all compounds reduced food intake to a comparable extent in both chow-fed young lean (3-5 months old) and middle-aged obese (12-14 months old) male and female mice. We provide a mechanism through which 5-HT anorectic potency is maintained with age, via preserved 5-HT-POMC appetitive anatomical machinery. Specifically, the abundance and signaling of the primary 5-HT receptor influencing appetite via POMC activation, the 5-HT2CR, is not perturbed with age. These data reveal that although 5-HT obesity medications require ARC POMC neurons to achieve appetitive effects, the anorectic efficacy is maintained with aging, findings of clinical significance to the global aging obese population.


Subject(s)
Aging/metabolism , Fenfluramine/therapeutic use , Obesity/drug therapy , Pro-Opiomelanocortin/metabolism , Selective Serotonin Reuptake Inhibitors/therapeutic use , Serotonin/metabolism , Aging/drug effects , Animals , Female , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Pro-Opiomelanocortin/genetics , Treatment Outcome
7.
J Neurosci ; 33(44): 17429-34, 2013 Oct 30.
Article in English | MEDLINE | ID: mdl-24174676

ABSTRACT

The mechanisms by which the excitatory neurotransmitter glutamate is recycled at synapses are currently unknown. By examining the functional expression of plasma membrane transporters at presynaptic terminals, we aim to elucidate some of the mechanisms of glutamate recycling. Using whole-cell voltage-clamp recordings from rat calyx of Held presynaptic terminals, our data show, for the first time, that the glutamate precursor glutamine causes the direct activation of an electrogenic, sodium-dependent presynaptic transporter, which supplies glutamine for generation of presynaptic glutamate and helps sustain synaptic transmission. Interestingly, the functional expression of this transporter at the presynaptic plasma membrane is dynamically controlled by electrical activity of the terminal, indicating that uptake of neurotransmitter precursors is controlled by the demand at an individual terminal. Induction of the transporter current is calcium-dependent and inhibited by botulinum neurotoxin C, demonstrating the involvement of SNARE-dependent exocytosis in inserting transporters into the plasma membrane when the terminal is active. Conversely, inactivity of the presynaptic terminal results in removal of transporters via clathrin-mediated endocytosis. To investigate whether the presynaptic glutamine transporter supplies the precursor for generating the synaptically released glutamate, we measured miniature EPSCs to assess vesicular glutamate content. When the presynaptic glutamate pool was turned over by synaptic activity, inhibiting the presynaptic glutamine transporters with MeAIB reduced the miniature EPSC amplitude significantly. This demonstrates that presynaptic glutamine transport is centrally involved in the production of glutamate and assists in maintaining excitatory neurotransmission.


Subject(s)
Amino Acid Transport Systems, Neutral/biosynthesis , Brain Stem/physiology , Glutamic Acid/physiology , Glutamine/biosynthesis , Presynaptic Terminals/metabolism , Synapses/metabolism , Synaptic Transmission/physiology , Amino Acid Transport Systems, Neutral/antagonists & inhibitors , Amino Acid Transport Systems, Neutral/physiology , Animals , Biological Transport, Active/physiology , Brain Stem/metabolism , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Female , Glutamic Acid/metabolism , Glutamine/metabolism , Glutamine/physiology , Male , Organ Culture Techniques , Rats , Rats, Wistar , Synapses/physiology , Synaptic Transmission/drug effects , beta-Alanine/analogs & derivatives , beta-Alanine/pharmacology
8.
J Neurosci ; 33(23): 9800-4, 2013 Jun 05.
Article in English | MEDLINE | ID: mdl-23739976

ABSTRACT

An essential component of the neural network regulating ingestive behavior is the brain 5-hydroxytryptamine2C receptor (5-HT2CR), agonists of which suppress food intake and were recently approved for obesity treatment by the US Food and Drug Administration. 5-HT2CR-regulated appetite is mediated primarily through activation of hypothalamic arcuate nucleus (ARC) pro-opiomelanocortin (POMC) neurons, which are also disinhibited through a 5-HT1BR-mediated suppression of local inhibitory inputs. Here we investigated whether 5-HT2CR agonist anorectic potency could be significantly enhanced by coadministration of a 5-HT1BR agonist and whether this was associated with augmented POMC neuron activation on the population and/or single-cell level. The combined administration of subanorectic concentrations of 5-HT2CR and 5-HT1BR agonists produced a 45% reduction in food intake and significantly greater in vivo ARC neuron activation in mice. The chemical phenotype of activated ARC neurons was assessed by monitoring agonist-induced cellular activity via calcium imaging in mouse POMC-EGFP brain slices, which revealed that combined agonists activated significantly more POMC neurons (46%) compared with either drug alone (∼25% each). Single-cell electrophysiological analysis demonstrated that 5-HT2CR/5-HT1BR agonist coadministration did not significantly potentiate the firing frequency of individual ARC POMC-EGFP cells compared with agonists alone. These data indicate a functional heterogeneity of ARC POMC neurons by revealing distinct subpopulations of POMC cells activated by 5-HT2CRs and disinhibited by 5-HT1BRs. Therefore, coadministration of a 5-HT1BR agonist potentiates the anorectic efficacy of 5-HT2CR compounds by increasing the number, but not the magnitude, of activated ARC POMC neurons and is of therapeutic relevance to obesity treatment.


Subject(s)
Appetite Depressants/administration & dosage , Eating/physiology , Neurons/metabolism , Pro-Opiomelanocortin/metabolism , Serotonin 5-HT1 Receptor Agonists/administration & dosage , Serotonin 5-HT2 Receptor Agonists/administration & dosage , Animals , Drug Synergism , Drug Therapy, Combination , Eating/drug effects , Feeding Behavior/drug effects , Feeding Behavior/physiology , Female , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neurons/drug effects , Organ Culture Techniques , Pro-Opiomelanocortin/antagonists & inhibitors , Treatment Outcome
9.
J Physiol ; 590(10): 2317-31, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22411007

ABSTRACT

Stimulation of astrocytes by neuronal activity and the subsequent release of neuromodulators is thought to be an important regulator of synaptic communication. In this study we show that astrocytes juxtaposed to the glutamatergic calyx of Held synapse in the rat medial nucleus of the trapezoid body (MNTB) are stimulated by the activation of glutamate transporters and consequently release glutamine on a very rapid timescale. MNTB principal neurones express electrogenic system A glutamine transporters, and were exploited as glutamine sensors in this study. By simultaneous whole-cell voltage clamping astrocytes and neighbouring MNTB neurones in brainstem slices, we show that application of the excitatory amino acid transporter (EAAT) substrate d-aspartate stimulates astrocytes to rapidly release glutamine, which is detected by nearby MNTB neurones. This release is significantly reduced by the toxins L-methionine sulfoximine and fluoroacetate, which reduce glutamine concentrations specifically in glial cells. Similarly, glutamine release was also inhibited by localised inactivation of EAATs in individual astrocytes, using internal DL-threo-ß-benzyloxyaspartic acid (TBOA) or dissipating the driving force by modifying the patch-pipette solution. These results demonstrate that astrocytes adjacent to glutamatergic synapses can release glutamine in a temporally precise, controlled manner in response to glial glutamate transporter activation. Since glutamine can be used by neurones as a precursor for glutamate and GABA synthesis, this represents a potential feedback mechanism by which astrocytes can respond to synaptic activation and react in a way that sustains or enhances further communication. This would therefore represent an additional manifestation of the tripartite relationship between synapses and astrocytes.


Subject(s)
Astrocytes/physiology , Glutamic Acid/physiology , Glutamine/physiology , Synaptic Transmission/physiology , Animals , Brain Stem/physiology , Excitatory Amino Acid Transporter 1/physiology , Excitatory Amino Acid Transporter 2/physiology , Feedback, Physiological , Neurons/physiology , Rats , Rats, Wistar
10.
J Neurosci Methods ; 177(2): 273-84, 2009 Mar 15.
Article in English | MEDLINE | ID: mdl-19014970

ABSTRACT

Electroporation creates transient pores in the plasma membrane to introduce macromolecules within a cell or cell population. Generally, electrical pulses are delivered between two electrodes separated from each other, making electroporation less likely to be localised. We have developed a new device combining local pressure ejection with local electroporation through a double-barrelled glass micropipette to transfer impermeable macromolecules in brain slices or in cultured HEK293 cells. The design achieves better targeting of the site of pressure ejection with that of electroporation. With this technique, we have been able to limit the delivery of propidium iodide or dextran amine within areas of 100-200 micrometer. We confirm that local electroporation is transient and show that when combined with pressure ejection, it allows local transfection of EGFP plasmids within HEK293 cells or within cerebellar and hippocampal slice cultures. We further show that local electroporation is less damaging when compared to global electroporation using two separate electrodes. Focal delivery of dextran amine dyes within trapezoid body fibres allowed tracing axonal tracts within brainstem slices, enabling the study of identified calyx of Held presynaptic terminals in living brain tissue. This labelling method can be used to target small nuclei in neuronal tissue and is generally applicable to the study of functional synaptic connectivity, or live axonal tracing in a variety of brain areas.


Subject(s)
Coloring Agents , Electroporation/methods , Fluorescent Dyes , Microinjections/methods , Neuroanatomy/methods , Staining and Labeling/methods , Animals , Auditory Pathways/cytology , Brain Stem/cytology , Cell Line , Cell Membrane/drug effects , Dextrans , Electronics, Medical/instrumentation , Electronics, Medical/methods , Electroporation/instrumentation , Humans , Microelectrodes , Microinjections/instrumentation , Neuroanatomy/instrumentation , Organ Culture Techniques , Pressure , Presynaptic Terminals/ultrastructure , Propidium , Rats , Staining and Labeling/instrumentation
11.
J Neurosci ; 26(39): 9983-95, 2006 Sep 27.
Article in English | MEDLINE | ID: mdl-17005862

ABSTRACT

Gq-protein-coupled receptors (GqPCRs) are widely distributed in the CNS and play fundamental roles in a variety of neuronal processes. Their activation results in phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis and Ca2+ release from intracellular stores via the phospholipase C (PLC)-inositol 1,4,5-trisphosphate (IP3) signaling pathway. Because early GqPCR signaling events occur at the plasma membrane of neurons, they might be influenced by changes in membrane potential. In this study, we use combined patch-clamp and imaging methods to investigate whether membrane potential changes can modulate GqPCR signaling in neurons. Our results demonstrate that GqPCR signaling in the human neuronal cell line SH-SY5Y and in rat cerebellar granule neurons is directly sensitive to changes in membrane potential, even in the absence of extracellular Ca2+. Depolarization has a bidirectional effect on GqPCR signaling, potentiating thapsigargin-sensitive Ca2+ responses to muscarinic receptor activation but attenuating those mediated by bradykinin receptors. The depolarization-evoked potentiation of the muscarinic signaling is graded, bipolar, non-inactivating, and with no apparent upper limit, ruling out traditional voltage-gated ion channels as the primary voltage sensors. Flash photolysis of caged IP3/GPIP2 (glycerophosphoryl-myo-inositol 4,5-bisphosphate) places the voltage sensor before the level of the Ca2+ store, and measurements using the fluorescent bioprobe eGFP-PH(PLCdelta) (enhanced green fluorescent protein-pleckstrin homology domain-PLCdelta) directly demonstrate that voltage affects muscarinic signaling at the level of the IP3 production pathway. The sensitivity of GqPCR IP3 signaling in neurons to voltage itself may represent a fundamental mechanism by which ionotropic signals can shape metabotropic receptor activity in neurons and influence processes such as synaptic plasticity in which the detection of coincident signals is crucial.


Subject(s)
Calcium Signaling/physiology , Inositol 1,4,5-Trisphosphate/physiology , Membrane Potentials/physiology , Neurons/physiology , Phosphatidylinositol 4,5-Diphosphate/metabolism , Receptor, Muscarinic M3/physiology , 1-Methyl-3-isobutylxanthine/pharmacology , Animals , CHO Cells , Calcium Signaling/drug effects , Cell Line , Cell Line, Tumor , Cells, Cultured/physiology , Cerebellum/cytology , Cricetinae , Cricetulus , Humans , Inositol Phosphates/radiation effects , Isoenzymes/genetics , Isoenzymes/metabolism , Kidney/cytology , Kidney/embryology , Microscopy, Fluorescence , Neuroblastoma/pathology , Neuronal Plasticity , Nifedipine/pharmacology , Oxotremorine/pharmacology , Patch-Clamp Techniques , Phospholipase C delta , Photolysis , Rats , Receptor, Muscarinic M3/agonists , Receptor, Muscarinic M3/genetics , Recombinant Fusion Proteins/physiology , Thapsigargin/pharmacology , Transfection , Type C Phospholipases/genetics , Type C Phospholipases/metabolism
12.
J Neurophysiol ; 95(6): 3336-42, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16481462

ABSTRACT

Activation of presynaptic receptors plays an important role in modulation of transmission at many synapses, particularly during high-frequency trains of stimulation. Adenosine-triphosphate (ATP) is coreleased with several neurotransmitters and acts at presynaptic sites to reduce transmitter release; such presynaptic P2X receptors occur at inhibitory and excitatory terminals in the medial nucleus of the trapezoid body (MNTB). We have investigated the mechanism of purinergic modulation during high-frequency repetitive stimulation at the calyx of Held synapse. Suppression of calyceal excitatory postsynaptic currents (EPSCs) by ATP and ATPgammaS (100 microM) was mimicked by adenosine application and was blocked by DPCPX (10 microM), indicating mediation by adenosine A1 receptors. DPCPX enhanced EPSC amplitudes during high-frequency synaptic stimulation, suggesting that adenosine has a physiological role in modulating transmission at the calyx. The Luciferin-Luciferase method was used to probe for endogenous ATP release (at 37 degrees C), but no release was detected. Blockers of ectonucleotidases also had no effect on endogenous synaptic depression, suggesting that it is adenosine acting on A1 receptors, rather than degradation of released ATP, which accounts for presynaptic purinergic suppression of synaptic transmission during physiological stimulus trains at this glutamatergic synapse.


Subject(s)
Adenosine Triphosphate/metabolism , Auditory Pathways/physiology , Brain Stem/physiology , Excitatory Postsynaptic Potentials/physiology , Receptor, Adenosine A1/metabolism , Receptors, Purinergic P2/metabolism , Synaptic Transmission/physiology , Action Potentials/drug effects , Action Potentials/physiology , Adenosine/pharmacology , Adenosine A1 Receptor Agonists , Animals , Auditory Pathways/drug effects , Brain Stem/drug effects , Cells, Cultured , Excitatory Postsynaptic Potentials/drug effects , Neurons/drug effects , Neurons/physiology , Purinergic P2 Receptor Agonists , Rats , Receptors, Purinergic P2X , Synaptic Transmission/drug effects
13.
Neurosci Lett ; 382(1-2): 66-70, 2005.
Article in English | MEDLINE | ID: mdl-15911123

ABSTRACT

Vesicular glutamate transporters (VGLUTs) are responsible for the accumulation of the excitatory neurotransmitter glutamate into synaptic vesicles. It is currently controversial whether the two isoforms found in glutamatergic neurons, VGLUT1 and VGLUT2, are present at the same synapse or have entirely complementary patterns of distribution. Using fluorescent immunohistochemistry, this study examines the colocalization of these two transporters in the rat superior olivary complex (SOC) between postnatal day (P) 5 and 29. The medial and lateral superior olives (MSO; LSO) stain for both VGLUT1 and VGLUT2 at all ages studied, with VGLUT1 levels doubling over this developmental period and VGLUT2 levels remaining unchanged. The ventral nucleus of the trapezoid body (VNTB) strongly labels only for VGLUT2, despite the fact that glutamatergic synapses are present that are formed from collaterals of axons that go on to form synapses containing both VGLUT1 and VGLUT2. Principal neurons of the medial nucleus of the trapezoid body (MNTB) are surrounded by the calyx of Held presynaptic terminal, which is large enough to allow examination of VGLUT localization within a synapse. Throughout its postnatal developmental period a single calyx synapse contains both VGLUT1 and VGLUT2. Whereas VGLUT1 levels are greatly up-regulated from P5 to P29, VGLUT2 levels remain high. As the abundance of VGLUT determines the quantal size, this up-regulation will increase excitatory postsynaptic currents (EPSCs) and have influences on synaptic physiology.


Subject(s)
Membrane Transport Proteins/metabolism , Olivary Nucleus/metabolism , Aging/physiology , Animals , Excitatory Postsynaptic Potentials/physiology , Fluorescent Antibody Technique , Immunohistochemistry , Microscopy, Confocal , Olivary Nucleus/growth & development , Presynaptic Terminals/metabolism , Rats , Vesicular Glutamate Transport Protein 1 , Vesicular Glutamate Transport Protein 2
14.
J Physiol ; 565(Pt 3): 885-96, 2005 Jun 15.
Article in English | MEDLINE | ID: mdl-15845577

ABSTRACT

Presynaptic group III metabotropic glutamate receptor (mGluR) activation by exogenous agonists (such as L-2-amino-4-phosphonobutyrate (L-AP4)) potently inhibit transmitter release, but their autoreceptor function has been questioned because endogenous activation during high-frequency stimulation appears to have little impact on synaptic amplitude. We resolve this ambiguity by studying endogenous activation of mGluRs during trains of high-frequency synaptic stimuli at the calyx of Held. In vitro whole-cell patch recordings were made from medial nucleus of the trapezoid body (MNTB) neurones during 1 s excitatory postsynaptic current (EPSC) trains delivered at 200 Hz and at 37 degrees C. The group III mGluR antagonist (R,S)-cyclopropyl-4-phosphonophenylglycine (CPPG, 300 microm) had no effect on EPSC short-term depression, but accelerated subsequent recovery time course (tau: 4.6 +/- 0.8 s to 2.4 +/- 0.4 s, P = 0.02), and decreased paired pulse ratio from 1.18 +/- 0.06 to 0.97 +/- 0.03 (P = 0.01), indicating that mGluR activation reduced release probability (P). Modelling autoreceptor activation during repetitive stimulation revealed that as P declines, the readily releasable pool size (N) increases so that the net EPSC (NP) is unchanged and short-term depression proceeds with the same overall time course as in the absence of autoreceptor activation. Thus, autoreceptor action on the synaptic response is masked but the synapse is now in a different state (lower P, higher N). While vesicle replenishment clearly underlies much of the recovery from short-term depression, our results show that the recovery time course of P also contributes to the reduced response amplitude for 1-2 s. The results show that passive equilibration between N and P masks autoreceptor modulation of the EPSC and suggests that mGluR autoreceptors function to change the synaptic state and distribute metabolic demand, rather than to depress synaptic amplitude.


Subject(s)
Brain Stem/physiology , Receptors, Metabotropic Glutamate/physiology , Synapses/physiology , Animals , Autoreceptors/physiology , Excitatory Postsynaptic Potentials/physiology , Glycine/analogs & derivatives , Glycine/pharmacology , Models, Neurological , Neural Inhibition/physiology , Presynaptic Terminals/physiology , Rats , Receptors, Metabotropic Glutamate/antagonists & inhibitors
15.
J Biol Chem ; 279(47): 49036-44, 2004 Nov 19.
Article in English | MEDLINE | ID: mdl-15342646

ABSTRACT

Intracellular Ca2+ store release contributes to activity-dependent synaptic plasticity in the central nervous system by modulating the amplitude, propagation, and temporal dynamics of cytoplasmic Ca2+ changes. However, neuronal Ca2+ stores can be relatively insensitive to increases in the store-mobilizing messenger inositol 1,4,5-trisphosphate (IP3). Using a fluorescent biosensor we have visualized M1 muscarinic acetylcholine (mACh) receptor signaling in individual hippocampal neurons and observed increased IP3 production in the absence of concurrent Ca2+ store release. However, coincident glutamate-mediated synaptic activity elicited enhanced and oscillatory IP3 production that was dependent upon ongoing mACh receptor stimulation and S-alpha-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid receptor activation of Ca2+ entry. Moreover, the enhanced levels of IP3 now mobilized Ca2+ from intracellular stores that were refractory to the activation of mACh receptors alone. We conclude that convergent ionotropic and metabotropic receptor inputs can facilitate Ca2+ signaling by enhancing IP3 production as well as augmenting release by Ca2+-induced Ca2+ release.


Subject(s)
Calcium/metabolism , Hippocampus/cytology , Inositol 1,4,5-Trisphosphate/metabolism , Neurons/metabolism , Receptors, Muscarinic/metabolism , Synapses/metabolism , Animals , Biosensing Techniques , Cells, Cultured , Dose-Response Relationship, Drug , Electrophysiology , Fluorescent Dyes/pharmacology , Glutamic Acid/metabolism , Green Fluorescent Proteins/metabolism , Hippocampus/metabolism , Microscopy, Confocal , Microscopy, Fluorescence , Oscillometry , Picrotoxin/pharmacology , Plasmids/metabolism , Rats , Receptors, AMPA/metabolism , Time Factors , Transfection , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism
16.
Eur J Neurosci ; 18(10): 2899-902, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14656340

ABSTRACT

Principal neurons of the medial nucleus of the trapezoid body (MNTB) receive a synaptic input from a single giant calyx terminal that generates a fast-rising, large excitatory postsynaptic current (EPSC), each of which are supra-threshold for postsynaptic action potential generation. Here, we present evidence that MNTB principal neurons receive multiple excitatory synaptic inputs generating slow-rising, small EPSCs that are also capable of triggering postsynaptic action potentials but are of non-calyceal origin. Both calyceal and non-calyceal EPSCs are mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) and N-methyl-d-aspartate (NMDA) receptor activation; however, the NMDA receptor-mediated response is proportionally larger at the non-calyceal synapses. Non-calyceal synapses generate action potentials in MNTB principal neurons with a longer latency and a lower reliability than the large calyceal input. They constitute an alternative low fidelity synaptic input to the fast and secure relay transmission via the calyx of Held synapse.


Subject(s)
Auditory Pathways/physiology , Brain Stem/physiology , Neurons/physiology , Synaptic Transmission/physiology , Valine/analogs & derivatives , Anesthetics, Local/pharmacology , Animals , Animals, Newborn , Brain Stem/cytology , Electric Stimulation , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , In Vitro Techniques , Membrane Potentials/drug effects , Neurons/classification , Neurons/drug effects , Patch-Clamp Techniques/methods , Quinoxalines/pharmacology , Rats , Synaptic Transmission/drug effects , Tetrodotoxin/pharmacology , Time Factors , Valine/pharmacology , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology
17.
J Neurosci ; 23(12): 4868-77, 2003 Jun 15.
Article in English | MEDLINE | ID: mdl-12832509

ABSTRACT

Short-term facilitation and depression have a profound influence on transmission at many glutamatergic synapses, particularly during trains of stimuli. A major component of these processes is postsynaptic receptor desensitization. Both presynaptic and postsynaptic mechanisms can contribute to synaptic efficacy, but it is often difficult to define their respective contributions. Blockers of desensitization such as cyclothiazide (CTZ) can be used, but many of these drugs have nonspecific effects on transmitter release, complicating attempts to define synaptic effectiveness under physiological conditions. We describe and validate a new method to minimize desensitization during trains of synaptic stimuli that is based on the low-affinity competitive glutamate receptor antagonists gamma-D-glutamylglycine or kynurenic acid. A computational model of AMPA receptor kinetics shows that the mechanism can be accounted for by simple competitive antagonism of AMPA receptors, where the rapid off-rate of the antagonist permits re-equilibration between blocked and unblocked pools during the interstimulus interval. Our results at the calyx of Held show that desensitization makes little contribution to synaptic depression at frequencies below 10 Hz, but at higher frequencies it makes an important contribution, with accumulating desensitization masking short-term facilitation and causing an underestimation of quantal content. This novel method of protection from desensitization is compatible with physiological studies but cannot be used in conjunction with CTZ. Although presynaptic vesicle depletion makes the dominant contribution to short-term depression, our results show that AMPA receptor desensitization contributes to the depression at auditory synapses after hearing onset and in a frequency-dependent manner.


Subject(s)
Action Potentials/physiology , Neural Inhibition/physiology , Presynaptic Terminals/physiology , Synaptic Transmission/physiology , Action Potentials/drug effects , Animals , Auditory Pathways/physiology , Benzothiadiazines , Brain Stem/cytology , Brain Stem/drug effects , Brain Stem/physiology , Calcium/metabolism , Calcium/pharmacology , Dipeptides/pharmacology , Diuretics , Electric Stimulation , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , In Vitro Techniques , Models, Neurological , Neural Inhibition/drug effects , Neurons/metabolism , Neurons/physiology , Patch-Clamp Techniques , Rats , Rats, Inbred Strains , Receptors, AMPA/antagonists & inhibitors , Receptors, AMPA/metabolism , Sodium Chloride Symporter Inhibitors/pharmacology , Synaptic Transmission/drug effects , Time Factors
18.
J Physiol ; 550(Pt 1): 27-33, 2003 Jul 01.
Article in English | MEDLINE | ID: mdl-12777451

ABSTRACT

Voltage-gated K+ channels activating close to resting membrane potentials are widely expressed and differentially located in axons, presynaptic terminals and cell bodies. There is extensive evidence for localisation of Kv1 subunits at many central synaptic terminals but few clues to their presynaptic function. We have used the calyx of Held to investigate the role of presynaptic Kv1 channels in the rat by selectively blocking Kv1.1 and Kv1.2 containing channels with dendrotoxin-K (DTX-K) and tityustoxin-Kalpha (TsTX-Kalpha) respectively. We show that Kv1.2 homomers are responsible for two-thirds of presynaptic low threshold current, whilst Kv1.1/Kv1.2 heteromers contribute the remaining current. These channels are located in the transition zone between the axon and synaptic terminal, contrasting with the high threshold K+ channel subunit Kv3.1 which is located on the synaptic terminal itself. Kv1 homomers were absent from bushy cell somata (from which the calyx axons arise); instead somatic low threshold channels consisted of heteromers containing Kv1.1, Kv1.2 and Kv1.6 subunits. Current-clamp recording from the calyx showed that each presynaptic action potential (AP) was followed by a depolarising after-potential (DAP) lasting around 50 ms. Kv1.1/Kv1.2 heteromers had little influence on terminal excitability, since DTX-K did not alter AP firing. However TsTX-Kalpha increased DAP amplitude, bringing the terminal closer to threshold for generating an additional AP. Paired pre- and postsynaptic recordings confirmed that this aberrant AP evoked an excitatory postsynaptic current (EPSC). We conclude that Kv1.2 channels have a general presynaptic function in suppressing terminal hyperexcitability during the depolarising after-potential.


Subject(s)
Potassium Channels, Voltage-Gated , Potassium Channels/physiology , Presynaptic Terminals/physiology , Action Potentials/physiology , Animals , Axons/metabolism , Brain Stem/cytology , Brain Stem/metabolism , Delayed Rectifier Potassium Channels , Electric Conductivity , In Vitro Techniques , Kv1.1 Potassium Channel , Kv1.2 Potassium Channel , Potassium Channels/metabolism , Presynaptic Terminals/metabolism , Rats , Rats, Inbred Strains , Rats, Wistar
19.
J Neurosci ; 22(14): 5840-7, 2002 Jul 15.
Article in English | MEDLINE | ID: mdl-12122046

ABSTRACT

Beyond their role in generating ATP, mitochondria have a high capacity to sequester calcium. The interdependence of these functions and limited access to presynaptic compartments makes it difficult to assess the role of sequestration in synaptic transmission. We addressed this important question using the calyx of Held as a model glutamatergic synapse by combining patch-clamp with a novel mitochondrial imaging method. Presynaptic calcium current, mitochondrial calcium concentration ([Ca(2+)](mito), measured using rhod-2 or rhod-FF), cytoplasmic calcium concentration ([Ca(2+)](cyto), measured using fura-FF), and the postsynaptic current were monitored during synaptic transmission. Presynaptic [Ca(2+)](cyto) rose to 8.5 +/- 1.1 microM and decayed rapidly with a time constant of 45 +/- 3 msec; presynaptic [Ca(2+)](mito) also rose rapidly to >5 microM but decayed slowly with a half-time of 1.5 +/- 0.4 sec. Mitochondrial depolarization with rotenone and carbonyl cyanide p-trifluoromethoxyphenylhydrazone abolished mitochondrial calcium rises and slowed the removal of [Ca(2+)](cyto) by 239 +/- 22%. Using simultaneous presynaptic and postsynaptic patch clamp, combined with presynaptic mitochondrial and cytoplasmic imaging, we investigated the influence of mitochondrial calcium sequestration on transmitter release. Depletion of ATP to maintain mitochondrial membrane potential was blocked with oligomycin, and ATP was provided in the patch pipette. Mitochondrial depolarization raised [Ca(2+)](cyto) and reduced transmitter release after short EPSC trains (100 msec, 200 Hz); this effect was reversed by raising mobile calcium buffering with EGTA. Our results suggest a new role for presynaptic mitochondria in maintaining transmission by accelerating recovery from synaptic depression after periods of moderate activity. Without detectable thapsigargin-sensitive presynaptic calcium stores, we conclude that mitochondria are the major organelle regulating presynaptic calcium at central glutamatergic terminals.


Subject(s)
Calcium/metabolism , Mitochondria/metabolism , Synapses/metabolism , Synaptic Transmission/physiology , Adenosine Triphosphate/metabolism , Animals , Brain Stem/cytology , Brain Stem/drug effects , Brain Stem/physiology , Calcium Signaling/drug effects , Calcium Signaling/physiology , Cytoplasm/metabolism , Electric Stimulation , Enzyme Inhibitors/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Fluorescent Dyes , Glutamic Acid/metabolism , In Vitro Techniques , Mitochondria/drug effects , Oligomycins/pharmacology , Patch-Clamp Techniques , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Rats , Synapses/drug effects , Synaptic Transmission/drug effects , Uncoupling Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...